Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis.

- Eursiriwan, Sudarat, Okascharoen, Chusak, Vallibhakara, Sakda Arj-Ong, Pattanaprateep, Oraluck, Numthavaj, Pawin, Attia, John, Thakkinstian, Ammarin

Systematic review and network meta-analysis of intravenous ibuprofen vs. intravenous indomethacin vs. placebo in the management of clinically and/or echocardiographically important patent ductus arteriosus in preterm infants at greater than 24 hours of life

- Jones, Lisa Jane

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

- McGettigan, Patricia, Henry, David

Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants

- Jones, L. J., Craven, P. D., Attia, J., Thakkinstian, A., Wright, I.